InMed Pharmaceuticals Inc. (NASDAQ: INM)
$4.7900
+0.1400 ( -0.42% ) 28.6K
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
Market Data
Open
$4.7900
Previous close
$4.6500
Volume
28.6K
Market cap
$3.31M
Day range
$4.5490 - $4.9030
52 week range
$2.4140 - $15.6960
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-k | Annual reports | 93 | Sep 30, 2024 |
| 8-k | 8K-related | 16 | Sep 26, 2024 |
| 8-k | 8K-related | 15 | Sep 20, 2024 |
| 8-k | 8K-related | 16 | Aug 21, 2024 |
| 8-k | 8K-related | 15 | Aug 20, 2024 |
| 4 | Insider transactions | 1 | Aug 02, 2024 |
| 8-k | 8K-related | 15 | Jul 30, 2024 |
| 8-k | 8K-related | 16 | Jun 28, 2024 |
| 8-k | 8K-related | 15 | Jun 11, 2024 |
| 4 | Insider transactions | 1 | May 28, 2024 |